Loading clinical trials...
Loading clinical trials...
Assessment of the Improvement of the Cardiovascular Risk Profile in Obese Women After Correction of Iodine Deficiency
The study hypothesis is that iodine supplementation will lower serum TSH and leptin concentrations and thereby improve the lipid and glucose profile.
The study will be a double blind, placebo controlled intervention study in obese women living in the Atlas foot mountains in Morocco, an iodine deficient area. Eligible subjects will be randomized into intervention and control group and will receive the respective supplement for 6 months. At baseline, midpoint and endpoint anthropometric as well as metabolic profile will be assessed. A health questionnaire will further be administered monthly when the tablets for the following month are distributed. Urine samples to determine iodine status will also be collected monthly.
Age
20 - 50 years
Sex
FEMALE
Healthy Volunteers
Yes
Universite Caddi Ayad, Faculte de Medecine et de Pharmacie
Marrakesh, Morocco
University Cadi Ayyad, Faculte des Sciences
Marrakesh, Morocco
Start Date
November 1, 2013
Primary Completion Date
June 1, 2014
Completion Date
July 1, 2014
Last Updated
July 30, 2014
162
ACTUAL participants
Iodine tablet
DIETARY_SUPPLEMENT
Placebo tablet
DIETARY_SUPPLEMENT
Lead Sponsor
Swiss Federal Institute of Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05862376